Exacerbation ob underlying IPF, was deemed unrelated to the drug in the paper by Ikeda et al., because rechallenge with the drug did not lead to relapse of the exacerbation in the patient
The Pneumotox website uses cookies. By accessing or using our website, you consent to the
collection, use and disclosure of the garnered information in accordance with our privacy
policy.
